The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer

@inproceedings{Chen2017ThePO,
  title={The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer},
  author={Shouzhen Chen and Xujing Dai and Yifei Gao and Fang Shen and Jingxin Ding and Qi Chen},
  booktitle={Scientific Reports},
  year={2017}
}
The estrogen (ER) or progesterone receptors (PR) is positively associated with better clinical outcomes in ovarian cancer. Whether metastasis or recurrence of ovarian cancer is correlated with this association has not been investigated. Data on 894 women with epithelial ovarian cancer were collected and the association between ER or PR positivity and peritoneal or lymph node metastases or recurrence was analysed. ER or PR positivity was higher in high-grade, low-grade serous and endometrioid… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 51 REFERENCES

Biological Validation and Clinical Implications

Rambau, P. et al. Association of Hormone Receptor Expression Carcinoma
  • International journal of molecular sciences 18, 515–520
  • 2017

Clinicopathological correlation and immunohistochemical study

Naik, P. S. et al. Epithelial ovarian tumors
  • J Midlife Health 6, 178–183
  • 2015

Clinical significance of hormonal receptor status of malignant ovarian tumors

Tkalia, G I.
  • Exp Oncol 36,
  • 2014

Heat shock protein 27: a potential biomarker of peritoneal metastasis in epithelial ovarian cancer

M Zhao
  • Tumour Biol
  • 2014